-amyloid deposition begins in Alzheimer’s disease (AD) years before the onset of any clinical symptoms. It is therefore important to determine the temporal trajectories of amyloid deposition in these earliest stages in order to better understand their associations with progression to AD. A method for estimating the temporal trajectories of voxelwise amyloid as measured using longitudinal positron emission tomography (PET) imaging is presented. The method involves the estimation of a score for each subject visit based on the PET data that reflects their amyloid progression. This amyloid progression score allows subjects with similar progressions to be aligned and analyzed together. The estimation of the progression scores and the amyloid trajectory parameters are performed using an expectation-maximization algorithm. The correlations among the voxel measures of amyloid are modeled to reflect the spatial nature of PET images. Simulation results show that model parameters are captured well at a variety of noise and spatial correlation levels. The method is applied to longitudinal amyloid imaging data considering each cerebral hemisphere separately. The results are consistent across the hemispheres and agree with a global index of brain amyloid known as mean cortical DVR. Unlike mean cortical DVR, which depends on a priori defined regions, the progression score extracted by the method is data-driven and does not make assumptions about regional longitudinal changes. Compared to regressing on age at each voxel, the longitudinal trajectory slopes estimated using the proposed method show better localized longitudinal changes.
1 Introduction
-amyloid deposition is a neuropathological hallmark associated with Alzheimer’s disease (AD), and begins years before any cognitive symptoms of AD are evident [8]. Studying within-subject longitudinal changes is limited by the number of follow-up visits. The relatively short span of longitudinal positron emission tomograpy (PET) studies of amyloid deposition compared to its hypothesized timeline makes it difficult to extensively study the longitudinal brain amyloid changes that occur in the preclinical stages of AD.2 Method
2.1 Model
for subject i at visit j is assumed to be a linear transformation of age
:
are assumed to be uniformly distributed random variables on a fixed and large domain
. The collection of K biomarker measurements (the intensities at each PiB-PET DVR voxel reflecting amyloid levels) make up the
vector
. The longitudinal trajectories associated with these biomarkers are assumed have a linear form parameterized by
vectors
and
:
is the observation noise. The covariance matrix R is assumed to be of the form
, where
is a positive scalar and C is a correlation matrix parameterized by
. The parameters
make up
.2.2 Log-Likelihood Function
be the vector consisting of all biomarker measurements stacked across all visits of subject i and let
. We then define
and
, where n is the number of subjects. The pair
is the complete data. The complete log-likelihood for the model, ignoring the constants, is given by![$$\begin{aligned} \ell (\mathbf {y}, \mathbf {u} \mid \varvec{\theta })= & {} -\sum _{i,j} \left[ \log (\det \, R ) + \left( \mathbf {y}_{ij} - Z_{ij} \mathbf {u}_i - \mathbf {b} \right) ^T R^{-1} \left( \mathbf {y}_{ij} - Z_{ij} \mathbf {u}_i - \mathbf {b} \right) \right] , \; \; \; \; \end{aligned}$$](/wp-content/uploads/2016/09/A339424_1_En_33_Chapter_Equ3.gif)
and
.2.3 EM Algorithm Derivation
include biomarker measurements
at each visit. The hidden variables
are the subject-specific parameters
and
. The unknown parameters are
.
be the previous estimate of the parameters. The expectation step involves evaluating an expression for![$$\begin{aligned} E \left[ \ell \left( \mathbf {y}, \mathbf {u} \mid \varvec{\theta } \right) \mid \mathbf {y}, \varvec{\theta }' \right]= & {} \sum _i \int f(\tilde{\mathbf {u}}_i \mid \mathbf {y}_i, \varvec{\theta }') \ell \left( \mathbf {y}_i, \tilde{\mathbf {u}}_i \mid \varvec{\theta }\right) d\tilde{\mathbf {u}}_i. \end{aligned}$$](/wp-content/uploads/2016/09/A339424_1_En_33_Chapter_Equ4.gif)



, and
is a multivariate Gaussian density with mean
and covariance
. For ease of notation, we have used
to denote
stacked across the visits of subject i and
to denote diagonally stacked
matrices across the visits of subject i.
is obtained by diagonally stacking
across the visits of subject i.
allows us to write
, where c is a constant. Rewriting the expectation using Bayes’ rule and plugging in the result from (6) yields![$$\begin{aligned} E \left[ \ell \left( \mathbf {y}, \mathbf {u} \mid \varvec{\theta }\right) \mid \mathbf {y}, \varvec{\theta }' \right]\propto & {} \sum _i \int _\Omega \frac{\phi (\hat{\mathbf {u}}'_i; \tilde{\mathbf {u}}_i, S'_i)}{f(\mathbf {y}_i,\varvec{\theta }')} \ell \left( \mathbf {y}_i, \tilde{\mathbf {u}}_i \mid \varvec{\theta }\right) d\tilde{\mathbf {u}}_i. \end{aligned}$$](/wp-content/uploads/2016/09/A339424_1_En_33_Chapter_Equ8.gif)
is large enough, we can approximate the expectation as an infinite domain integration over
to obtain![$$\begin{aligned} E \left[ \ell \left( \mathbf {y}, \mathbf {u} \mid \varvec{\theta }\right) \mid \mathbf {y}, \varvec{\theta }' \right]\propto & {} \sum _i \int \phi (\hat{\mathbf {u}}'_i; \tilde{\mathbf {u}}_i, S'_i) \ell \left( \mathbf {y}_i, \tilde{\mathbf {u}}_i \mid \varvec{\theta }\right) d\tilde{\mathbf {u}}_i \\\propto & {} -\sum _{i,j} \log [\det R] -\sum _{i,j} (\mathbf {y}_{ij} - \mathbf {b})^T R^{-1} (\mathbf {y}_{ij} - \mathbf {b}) \nonumber \\&+ 2 \left( \sum _{i,j} s'_{ij} \mathbf {y}_{ij} - \mathbf {b} \sum _{i,j} s'_{ij} \right) ^T R^{-1} \mathbf {a} \nonumber \end{aligned}$$](/wp-content/uploads/2016/09/A339424_1_En_33_Chapter_Equ9.gif)

.
be the function obtained at the end of the E-step. We set the derivatives
and
equal to 0 and solve for the parameters to obtain


